JENNIFER DOUDNA was named the winner of the Lurie Prize in the Biomedical Sciences by the Foundation for the NIH.
The 10th annual ST. JUDE THANKS AND GIVING CAMPAIGN raised more than $97 million last holiday season to support the St. Jude Children's Research Hospital, a projected increase of more than 31 percent over the previous year. Since 2004, the campaign has raised nearly $485 million.
NOVARTIS acquired CoStim Pharmaceuticals Inc., a portfolio company developing monoclonal antibody drugs, for an undisclosed amount. The acquisition was announced by MPM Capital and Atlas Venture.
ROSWELL PARK CANCER INSTITUTE will collaborate with GenomOncology to develop an informatics solution that enables the association of next-generation sequencing results with knowledge resources to define actionable mutations.
ROCHE SERVICIOS S.A., a Roche affiliate, and Cancer Genetics Inc. have entered into a three-year agreement to expand molecular diagnostic cancer testing in Central America and the Caribbean.
THE DUKE-NUS GRADUATE MEDICAL SCHOOL Singapore has partnered with ImaginAb Inc. to establish a joint corporate laboratory to develop new in vivo molecular imaging agents to study cancer biology and immune function.
NORTH SHORE-LIJ CANCER INSTITUTE opened a $47 million radiation therapy facility.
MARGARET DIMOND was named president of the Karmanos Cancer Hospital, effective immediately.
JOHN CZAJKOWSKI, NCI deputy director for management, has accepted a position as executive dean of administration at Harvard Medical School. His start date will be June 2.
ISSAM MAKHOUL was named the inaugural recipient of the Laura F. Hutchins, M.D. Distinguished Chair for Hematology and Oncology at the University of Arkansas for Medical Sciences.
